- A topical corticosteroid containing 1% hydrocortisone acetate in a base of 10% urea.
- Hydrocortisone acetate containing provides anti-inflammatory, antipruritic, and
vasconstrictive benefits.
- Urea provides soothing, hydrating, and exfoliate benefits.
 Chlorine- and fluorine- free
formulation. No restrictions on duration of use. Favorable safety profile. No age restrictions. |  |
|
Important safety information about U-cort™
The most common adverse reactions include: burning, itching, irritation, dryness, folliculitis,
hypertrichosis and acneiform eruptions. Contains sodium bisulfite, a sulfite that may cause
allergic-type reactions. Pediatric patients may demonstrate greater susceptibility to topical
corticosteroid-induced HPA axis suppression and Cushing’s syndrome than mature patients
because of a larger skin surface area to body weight ratio. Administration of topical corticosteroids
to pediatric patients should be limited to the least amount compatible with an effective therapeutic
regimen.
U-cort™ and TaroPharma™ are trademarks of Taro Pharmaceuticals U.S.A., Inc. and/or its affiliates.
